Book Review: 'Hope Dies Last' visits visionaries fighting global warming
Alan Weisman has found an all-world cast of scientists, engineers and environmentalists who have dreamed big and worked passionately to repair some of the world's wrecked ecosystems and also to develop processes that, for example, use far less energy than we get from oil
Take Azzam Alwash, for example. An engineer, he lamented destruction of thousands of square miles of marshes in Iraq that date to Biblical times and were his birthplace. Birds, fish and other animals flourished in the wetlands until Saddam Hussein drained them to flush out enemies to his regime.
The wetlands in the world's hottest region were thought beyond resurrection.
Weisman writes that to Alwash, however, 'impossible often masks a lack of imagination.' He marshaled the resources to restore much of the wetlands and a miracle followed: wildlife returned..
Some of Weisman's chapters will make readers wish they had paid more attention in high school science and chemistry classes.
Scientists at the Massachusetts Institute of Technology have made astonishing progress in developing commercial-scale fusion energy that could produce great quantities of clean energy. Such breakthroughs are critical on a planet now dependent on fossil fuels, which produce carbon dioxide that traps heat in the atmosphere.
To those who scoff at mentions of human-caused environmental catastrophe as a hoax or fake news, consider this: Weisman's bibliography runs 74 pages. And the type is small. He spent several years researching and reporting on this book and visited a dozen countries.
'As long as we let them keep on, there is hope,' writes Weisman, referring to the people he writes about in this book.
News also has overtaken the publication of this book. President Trump's threats to withhold money from Harvard and other universities would have a drastic effect because so many of the world's brightest students come to study at American research universities, contributing to the steady stream of American scientific breakthroughs.
Weisman set out to find inspirational people doing extraordinary work to save the planet.
___
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
11 minutes ago
- Yahoo
OSU falls victim to budget cuts, putting a damper on scientific research
PORTLAND, Ore. (KOIN) — The awarding of an OSU microfluidics research fund of $45 million has been called off by the Trump administration, leaving researchers fumbling for options. Microfluidics, the scientific study of the behavior of liquid on a microscopic level, is a recently established field and is hoped to aid in the medical realm as well as the manufacturing of semiconductors, a partially conductive component of many day-to-day electronic devices. The grant's cancellation has been a source of upset for researchers, but OSU is already looking ahead to future opportunities. Anti-ICE protests escalate outside Southwest Portland facility 'While we are disappointed in the notification of the EDA award cancellation for CorMic [Corvallis Microfluidics Tech Hub], we fully intend to participate in the EDA's next Notice of Funding Opportunity and remain well positioned to further national security interests as a global leader in microfluidics for semiconductor manufacturing, ' Tom Weller, Gaulke Professor and Head said. 'Oregon State University will continue to work alongside HP and other partners to further the commercialization of new microfluidics-connected technologies for semiconductor manufacturing, biotechnology, and advanced materials manufacturing.' This is not an isolated incident, with Trump having attempted to cut billions in allocated federal funding to scientific research since the beginning of his current term. White House spokesperson Kush Desai said, 'The Trump administration is spending its first few months reviewing the previous administration's projects, identifying waste, and realigning our research spending to match the American people's priorities and continue our innovative dominance.' Universities are getting hit with the full force of these budget cuts, with biomedical research being classified as 'waste.' Just in February, the National Institutes of Health proposed cutting billions of dollars to OHSU research looking at cancer and heart disease, among other afflictions. These cuts were immediately met with lawsuits from, but not limited to, the Association of American Universities and 22 state attorneys general. These lawsuits are still in progress. The Association of American Universities' lawsuit called the NIH cuts 'flagrantly unlawful' and expressed concern that 'our country will lose its status as the destination for solving the world's biggest health problems.' Scientists of the NIH itself have begun to speak out, publicly disagreeing with the institute's actions, claiming that the cuts 'undermine the NIH mission.' Cuts to scientific research are becoming a recurring source of contention as Trump's second term continues. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
an hour ago
- Yahoo
Cyborg tadpoles ‘hold clues to origin of autism'
Cyborg tadpoles with electrodes grown into their brains have been created by Harvard scientists to help study autism and schizophrenia. Tiny flexible electrodes were implanted into tadpole embryos when they were days old, allowing them to completely embed into the central nervous system as the amphibians is the first time that researchers have shown it is possible to create a device that integrates seamlessly into the brain while it develops. Usually, scientists implant metal electrodes into mature brains to monitor brain cell activity, but by then, the critical early stages of development are over and the process often causes some neuronal damage. Neurological conditions such as autism, bipolar disorder and schizophrenia are thought to be 'baked in' to the brain early on, so being able to watch the brain developing could offer vital clues into why they develop. 'Autism, bipolar disorder, schizophrenia – these all could happen at early developmental stages,' said Dr Jia Liu, assistant professor of bioengineering at Harvard School of Engineering and Applied Sciences. 'There is just no ability currently to measure neural activity during early neural development. Our technology will really enable an uncharted area. 'If we can fully leverage the natural development process, we will have the ability to implant a lot of sensors across the 3D brain non-invasively, and at the same time, monitor how brain activity gradually evolves over time. No one has ever done this before.' To create the cyborg tadpoles, scientists used soft, stretchy implantable ribbons containing dozens of sensors capable of recording the activity of single neurons in the brain. The probes were developed at Harvard and are made from a material known as a 'fluorinated elastomer', similar to Teflon, which can live stably in the brain for several months. It is as soft as biological tissue but can be engineered into highly resilient electronic components that can house multiple sensors for recording brain activity. The ribbons were implanted on an area of the embryo called the 'neural plate', which is the earliest stage of the nervous system. As the embryo develops, the plate bends into a u-shape, taking the ribbon probes inside. By the time the neural plate has grown into the neural tube – the basis of the brain and central nervous system – the electronics are completely embedded inside, where they can give a read-out of how the neurons are firing and communicating with each other. Researchers say the device can record electrical activity from single brain cells with millisecond precision, with no impact on normal tadpole embryo development or behaviour. By integrating their stretchable device into the neural plate, the researchers showed they could continuously monitor brain activity during each embryonic stage. 'These so-called cyborg tadpoles offer a glimpse into a future in which profound mysteries of the brain could be illuminated, and diseases that manifest in early development could be understood, treated or cured,' Harvard said in a press notice about the new technology. The research is published in the journal Nature. Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more.
Chicago Tribune
2 hours ago
- Chicago Tribune
New paper sheds light on experience of Black prisoners in infamous Stateville prison malaria experiments
Much has been said and written over the years about controversial malaria research conducted on inmates at Illinois' Stateville Penitentiary starting in the 1940s. But at least one part of that story has been largely ignored until now: the role of Black prisoners in that research, which helped lead to the modern practice of using genetic testing to understand how individual patients will react to certain medications, according to the authors of a newly published paper out of the University of Utah. 'We want to highlight the stories of Black prisoners that participated in this prison research in the 1950s onward and give them their due,' said Hannah Allen, a medical ethicist and assistant professor of philosophy at the University of Texas Rio Grande Valley, and first author of the paper, which was published as an opinion piece Wednesday in the Journal of the American Medical Association. 'They haven't been properly acknowledged in the past, and their participation in these studies was really foundational in launching the field of pharmacogenetics and, later on, precision medicine,' said Allen, who recently completed her doctorate at the University of Utah. Starting in the 1940s, researchers infected inmates at the Joliet-area prison with malaria to test the effectiveness of drugs to treat the illness as part of a U.S. military-funded effort to protect American troops overseas, according to the paper. A University of Chicago doctor was the principal investigator. The inmates consented to being part of the studies and were paid for their participation. At first, the research was greeted with enthusiasm. In 1945, Life magazine ran a spread about it, featuring a photo of a Stateville inmate with cups containing malaria-carrying mosquitoes pressed against his bare chest. The first line of the story reads, 'In three U.S. penitentiaries men who have been imprisoned as enemies of society are now helping science fight another enemy of society.' But as the years passed, attitudes began to shift. Questions arose about whether inmates could truly, freely consent to participate in medical experiments or whether they felt coerced into them because of their often dire circumstances. At the Nuremberg trials, defense attorneys for Nazi doctors introduced text and images from the Life article about Stateville prison, though an Illinois physician argued at the trials that the prisoners in Stateville consented to being part of medical research whereas Nazi prisoners did not, according to the JAMA paper. In the mid-1970s, news broke about a study at Tuskegee, in which Black men with syphilis went untreated for years — news that raised awareness of ethical problems in medical research. News outlets also began publishing more stories about prison research, according to the JAMA article. The Chicago Tribune published an article in 1973, in which an inmate participating in the Stateville malaria research said: 'I've been coerced into the project — for the money. Being here has nothing to do with 'doing good for mankind' … I didn't want to keep taking money from my family.' The experiments at Stateville came to a halt in the 1970s. A number of protections and regulations are now in place when it comes to research involving prisoners. Since the 1970s, the Stateville research has often been discussed and analyzed but little attention has been paid to its Black participants, said James Tabery, a medical ethicist and philosophy professor at the University of Utah who led the new research, which was funded by the federal National Institutes of Health. For a time, Black prisoners were excluded from the studies because of a myth that Black people were immune to malaria, Tabery said. Later on, once scientists had pinpointed the drug primaquine as an effective medication for malaria, they turned their attention to the question of why 5% to 10% of Black men experienced a violent reaction to the drug, according to the paper. Ultimately, the scientists were successful, finding that the adverse reaction was related to a specific genetic deficiency. 'There are people all over Chicago today that are getting tested, that clinicians are recommending they get a genetic test before they get prescribed a drug because they want to make sure that their patient isn't going to have an adverse reaction to the drug,' Tabery said. 'It's really sort of powerful and interesting that you can trace that approach to doing good clinical medicine right back to this particular moment and place and population.' But Tabery and Allen also found that the Black prisoners were not treated the same as the white prisoners who participated in research at Stateville. For one, they weren't paid as much as the white prisoners, the rationale being that the white prisoners were infected with malaria, whereas the Black prisoners were given the drug but not infected with the disease — though some of the Black prisoners got very ill after taking the medication, according to the paper. Also, researchers didn't protect the Black participants' privacy as well as they did for other participants. They published certain identifying information about the Black participants, such as initials, ages, heights and weights, whereas participants in the previous research were represented with case numbers, according to the paper. Researchers also recruited the Black prisoners' family members for the study, which they didn't do with earlier participants, according to the paper. 'You see them just doing things with the Black prisoners that they're not doing with the white prisoners,' Tabery said. Also, though scientists made an important discovery through the research on Black prisoners, the episode also highlights the difficulty that can occur in translating discoveries into real life help for patients. Though the World Health Organization now recommends genetic testing to protect people who are sensitive to antimalarials, many of the people who would benefit most from such testing still don't receive it because of financial barriers, supply chain issues and a lack of training, according to the paper. 'What we found is when you sort of shift to what was happening to the Black prisoners, these other lessons you hadn't thought of as being derivable from Stateville suddenly do become apparent,' Tabery said.
